Back to Search
JAMES RIGAS, M.D.
M.D.
Medical Oncology Physician
NPI: 1639192313Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
9354(NH)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Current treatment paradigms for locally advanced non-small cell lung cancer.
PMID 17589303·J Thorac Oncol·2007
6-review
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer.
PMID 16551518·Lung Cancer·2005
8-other
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer.
PMID 16557670·Lung Cancer·2005
6-review
Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
PMID 15632250·Oncologist·2005
6-review
Taxane-platinum combinations in advanced non-small cell lung cancer: a review.
PMID 15161987·Oncologist·2004
4-observational
Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
PMID 11441410·Semin Oncol·2001
6-review
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC).
PMID 19524318·Lung Cancer·2010
3-trial
Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.
PMID 18024870·J Clin Oncol·2007
8-other
Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.
PMID 17551300·Am J Clin Oncol·2007
3-trial
Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
PMID 17442999·J Clin Oncol·2007
3-trial
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer.
PMID 17363535·Clin Cancer Res·2007
3-trial
Uncovering novel targets for cancer chemoprevention.
PMID 17302201·Recent Results Cancer Res·2007
6-review
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
PMID 17141357·Lung Cancer·2007
3-trial
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.
PMID 17000884·Clin Appl Thromb Hemost·2006
4-observational
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
PMID 15713522·Lung Cancer·2005
3-trial
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
PMID 15972865·N Engl J Med·2005
3-trial
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
PMID 15735921·J Neurooncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL CENTER DR
LEBANON, NH 03756 - Phone
- (603) 650-6344
Quick Facts
- NPI
- 1639192313
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile